Drugs / EBV-CTL CD19CAR zeta
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00709033 | Jul 2009 → May 2012 | chronic lymphocytic leukemia/small lymphocytic lymphoma | Baylor College of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EBV-CTL CD19CAR zeta | “PBTL CD19CAR-28 zeta 2x10exp7 cells/m2 and EBV-CTL CD19CAR zeta 2x10exp7 cells/m2” NCT00709033 ↗ |
| Modality | Cell therapy | “Adoptive transfer of T lymphocytes expressing a CD19-specific chimeric antigen receptor (CAR.CD19)” PMID 24782509 ↗ Apr 2014 |
| Route | Intravenous | “The patient will be given an injection of cells into the vein through an IV line at the assigned dose” NCT00709033 ↗ |